stoxline Quote Chart Rank Option Currency Glossary
  
Virtus LifeSci Biotech Clinical Trials ETF (BBC)
28.88  -0.76 (-2.56%)    10-10 15:59
Open: 29.735
High: 29.735
Volume: 37,016
  
Pre. Close: 29.64
Low: 28.3519
Market Cap: 18(M)
Technical analysis
2025-10-10 4:34:58 PM
Short term     
Mid term     
Targets 6-month :  34.73 1-year :  40.56
Resists First :  29.73 Second :  34.73
Pivot price 27.37
Supports First :  26.07 Second :  23.8
MAs MA(5) :  28.79 MA(20) :  26.63
MA(100) :  22.27 MA(250) :  22.58
MACD MACD :  1.4 Signal :  1.2
%K %D K(14,3) :  93.8 D(3) :  94.2
RSI RSI(14): 71.1
52-week High :  31.64 Low :  13.42
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ BBC ] has closed below upper band by 21.7%. Bollinger Bands are 96.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 29.77 - 29.93 29.93 - 30.06
Low: 27.99 - 28.16 28.16 - 28.31
Close: 28.59 - 28.89 28.89 - 29.14
Company Description

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Headline News

Tue, 09 Sep 2025
Best-Performing ETFs of Last Week - Yahoo Finance

Wed, 07 May 2025
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga

Wed, 17 Apr 2024
The 5 Best Biotech ETFs of 2024 - ETF.com

Mon, 24 Apr 2023
ALPS’ Biotech ETF SBIO Week's Top Performer - ETF Trends

Tue, 20 Sep 2022
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - FA Mag

Mon, 13 Sep 2021
Biotech Stocks Have Colds, but They Can Heal - ETF Trends

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Financial Services
Industry:
Asset Management
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android